BILL Holdings, Inc. (BILL) · Nov 20, 2026 · Acquisition
$6.0B acquisition — $63.25 per share, all cash; key stockholders committed to vote for merger
BILL’s acquisition filing shows key shareholders committed to the TPG-led deal, reducing execution risk as the $6 billion take-private moves forward.
BILL is a small-business finance and payments platform trying to improve efficiency, profitability and product reach while investing in AI; the new event shifts the story from executing that standalone plan to being taken private by TPG in partnership with Corpay. BILL’s latest filings describe a business still balancing growth investments, restructuring and profitability, while the transaction announcement values it at approximately $6.0 billion in cash at $63.25 per share and is expected to close in the first half of 2027.
The support agreement reduces one of the deal’s clearest execution risks. Certain stockholders have committed to show up, vote their covered shares for the merger and oppose competing proposals. 〔0〕 They also cannot freely transfer those shares, solicit an alternative transaction or support a rival bid while the agreement remains active. 〔1〕
This is confirmation and reinforcement, not a new economic upside surprise. The acquisition itself was announced on November 19, 2026, so the market already knew the central transaction; this filing adds contractual evidence that important holders are aligned behind it. The agreement also waives appraisal rights for the covered shares, further limiting routes to challenge or delay the transaction. 〔2〕
The deal still has meaningful closing steps ahead. The voting commitment ends if the merger agreement is terminated, if consideration is reduced or otherwise worsened for stockholders, or once stockholder approval is obtained, so it strengthens the path to a vote but does not make closing unconditional. The broader transaction remains subject to stockholder and regulatory approvals and customary closing conditions.
Bottom line: This filing makes BILL’s announced take-private deal more executable by locking in shareholder support and constraining competing bids. It matters as a risk-reduction step, but it does not change the already disclosed price or the broader transaction thesis.
Stockholder vote and regulatory approvals, expected first half 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!